Laura Perna

Dr. Laura Perna


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LPLaura Perna
Laura Perna
GSGrace Salsbury
Grace Salsbury
MDMohammed Dushti
Mohammed Dushti
CSChris J Smith
Chris J Smith
VMValle Morales
Valle Morales
PCPaul Chapple
Paul Chapple
Mitochondrial dysfunction is implicated in the pathogenesis of the neurological condition autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), yet precisely how the mitochondrial metabolism is affected is unknown. Thus, to better understand changes in the mitochondrial metabolism caused by loss of the sacsin protein (encoded by the SACS gene, which is mutated in ARSACS), we performed mass spectrometry-based tracer analysis, with both glucose- and glutamine-traced carbon. Comparing the metabolite profiles between wild-type and sacsin-knockout cell lines revealed increased reliance on aerobic glycolysis in sacsin-deficient cells, as evidenced by the increase in lactate and reduction of glucose. Moreover, sacsin knockout cells differentiated towards a neuronal phenotype had increased levels of tricarboxylic acid cycle metabolites relative to the controls. We also observed disruption in the glutaminolysis pathway in differentiated and undifferentiated cells in the absence of sacsin. In conclusion, this work demonstrates consequences for cellular metabolism associated with a loss of sacsin, which may be relevant to ARSACS.

7 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
LPLaura Perna
Laura Perna
GSGrace Salsbury
Grace Salsbury
MDMohammed Dushti
Mohammed Dushti
CSChris J Smith
Chris J Smith
VMValle Morales
Valle Morales
PCPaul Chapple
Paul Chapple
Mitochondrial dysfunction is implicated in the pathogenesis of the neurological condition Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay (ARSACS), yet precisely how mitochondrial metabolism is affected is unknown. Thus, to better understand changes in mitochondrial metabolism caused by loss of the sacsin protein (encoded by the SACS gene, that is mutated in ARSACS) we performed mass spectrometry-based tracer analysis, with both glucose and glutamine traced carbon. Comparing the metabolite profiles between wild-type and sacsin-knockout cell lines revealed increased reliance on aerobic glycolysis in sacsin-deficient cells, as evidenced by the increase in lactate and reduction of glucose. Moreover, sacsin knockout cells differentiated towards a neuronal phenotype had increased levels of tricarboxylic acid cycle metabolites relative to controls. We also observed disruption in the glutaminolysis pathway in differentiated and undifferentiated cells in the absence of sacsin. In conclusion, this work demonstrates consequences for cellular metabolism associated with loss of sacsin, which may be relevant to ARSACS.